Search
China Animal Husbandry Co., Ltd. Receives Approval for Clinical Trials of African Swine Fever Subunit Vaccine
1 week ago /
Read about 0 minute
Author：小编
China Animal Husbandry Co., Ltd. has announced that it has secured approval from the Ministry of Agriculture and Rural Affairs to commence clinical trials for its African Swine Fever Subunit Vaccine. This vaccine, developed jointly by the company and scientific research institutions since 2023 with a total investment of approximately RMB 46,244,600, aims to safeguard against African swine fever virus infection. It's important to note that the vaccine will only be available for market distribution and sale upon the successful completion of clinical trials and subsequent registration approval, a process that entails risks and uncertainties.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
